Cargando…

Reporting Quality of Randomized Controlled Trials for the Treatment of Eczema with Chinese Patent Medicine Based on the CONSORT-CHM Formulas 2017

OBJECTIVE: Chinese patent medicine (CPM) has been widely used to treat eczema in mainland China for decades. This study aims to investigate circulating CPM for eczema in mainland China and to evaluate the reporting quality of randomized controlled trials (RCTs) of them by using the CONSORT-CHM formu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ming, Zhou, Boyang, Zhou, Lihong, Li, Linfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512083/ https://www.ncbi.nlm.nih.gov/pubmed/33014102 http://dx.doi.org/10.1155/2020/2949125

Ejemplares similares

Efficacy and Safety of Runzao Zhiyang Capsule as an Add-On Therapy for Chronic Eczema: A Systematic Review and Meta-Analysis
por: Li, Ming, et al.
Publicado: (2021)

Novel CHM mutations identified in Chinese families with Choroideremia
por: Cai, Xue-Bi, et al.
Publicado: (2016)

Efficacy and Safety of Qingpeng Ointment for Subacute and Chronic Eczema: A Systematic Review and Meta-Analysis
por: Li, Yan, et al.
Publicado: (2021)

Genome and transcriptome of Papaver somniferum Chinese landrace CHM indicates that massive genome expansion contributes to high benzylisoquinoline alkaloid biosynthesis
por: Pei, Li, et al.
Publicado: (2021)

Chinese herbal medicine research in eczema treatment
por: Hon, Kam Lun, et al.
Publicado: (2011)

Association between Chinese herbal medicine (CHM) treatment and depression among cancer patients in China: An outpatient-based cross-sectional study
por: Lin, Huiyue, et al.
Publicado: (2023)

Does Chinese herbal medicine (CHM) reduce colorectal adenoma (CRA) recurrence: protocol of a registry-based, cohort study and a qualitative interview
por: Cheng, Yi, et al.
Publicado: (2023)

New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches
por: Jia, Kexin, et al.
Publicado: (2023)

The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype
por: Simunovic, Matthew P., et al.
Publicado: (2016)

Synonymous Variant in the CHM Gene Causes Aberrant Splicing in Choroideremia
por: da Palma, Mariana Matioli, et al.
Publicado: (2020)

IJD(®): Consorting with CONSORT 2010
por: Panda, Saumya, et al.
Publicado: (2013)

Iodized Phenol—“Battey’s Formula”—in Eczema Marginatum
por: Bellamy, W. J. H.
Publicado: (1880)

Quality of reporting of trial abstracts needs to be improved: using the CONSORT for abstracts to assess the four leading Chinese medical journals of traditional Chinese medicine
por: Wang, Ling, et al.
Publicado: (2010)

In silico data analyses of the hotspot mutations of CHM gene in choroideremia disease
por: Imani, Saber, et al.
Publicado: (2018)

Identification of Pathogenic Variants in the CHM Gene in Two Korean Patients With Choroideremia
por: Bae, Kunho, et al.
Publicado: (2017)

Are Michigan State University medical school (MSU-CHM) alumni more likely to practice in the region of their graduate medical education primary care program compared to non-MSU-CHM alumni?
por: Switzer, Richard, et al.
Publicado: (2018)

Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19
por: Ni, Li, et al.
Publicado: (2020)

AMFormulaS: an intelligent retrieval system for traditional Chinese medicine formulas
por: Cui, Yidi, et al.
Publicado: (2021)

Gene Augmentation of CHM Using Non-Viral Episomal Vectors in Models of Choroideremia
por: Toualbi, Lyes, et al.
Publicado: (2023)

Prof. Diana R. Elbourne: CONSORT for Cluster Randomized Trials and CONSORT for Noninferiority and Equivalence Trials
por: Du, Kathy J., et al.
Publicado: (2022)

Antipruritic Effect of Qingpeng Ointment on the Localized Nonexudative Eczema
por: Li, Yan, et al.
Publicado: (2019)

Expert Consensus on the Treatment of Hypertension with Chinese Patent Medicines
por: Wang, Li Ying, et al.
Publicado: (2013)

Atheroprotective Effects and Mechanisms of Postmarketing Chinese Patent Formulas in Atherosclerosis Models: A Systematic Review
por: Chen, Shiqi, et al.
Publicado: (2021)

Challenges and patenting strategies for Chinese herbal medicine
por: Wang, Xinsheng, et al.
Publicado: (2010)

Novel CHM mutations in Polish patients with choroideremia – an orphan disease with close perspective of treatment
por: Skorczyk-Werner, Anna, et al.
Publicado: (2018)

Expanding the genetic spectrum of choroideremia in an Australian cohort: report of five novel CHM variants
por: McLaren, Terri L., et al.
Publicado: (2020)

Molecular Characterization of Choroideremia-Associated Deletions Reveals an Unexpected Regulation of CHM Gene Transcription
por: Fioretti, Tiziana, et al.
Publicado: (2021)

Author Response to Letter to the Editor from CHM van den Ende et al
por: Álvarez, et al.
Publicado: (2020)

excluderanges: exclusion sets for T2T-CHM13, GRCm39, and other genome assemblies
por: Ogata, Jonathan D, et al.
Publicado: (2023)

Consort music
por: Dowland, John, 1563?-1626
Publicado: (1987)

The CONSORT statement
por: Cuschieri, Sarah
Publicado: (2019)

DNA based identification of medicinal materials in Chinese patent medicines
por: Chen, Rong, et al.
Publicado: (2012)

Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol
por: Xu, Kai, et al.
Publicado: (2022)

Efficacy and Safety of Mucopolysaccharide Polysulfate Cream for Non-Exudative Eczema: A Systematic Review and Meta-Analysis
por: Li, Ming, et al.
Publicado: (2021)

Jingtong Granule: A Chinese Patent Medicine for Cervical Radiculopathy
por: Zhu, Liguo, et al.
Publicado: (2015)

Rac1 Is Required for Pathogenicity and Chm1-Dependent Conidiogenesis in Rice Fungal Pathogen Magnaporthe grisea
por: Chen, Jisheng, et al.
Publicado: (2008)

CPMCP: a database of Chinese patent medicine and compound prescription
por: Sun, Chang, et al.
Publicado: (2022)

Protocol for the development of a reporting guideline for clinical trials with integrated Chinese and western medicine interventions: the CONSORT extension for ICWM
por: Wang, Juan, et al.
Publicado: (2023)

The CONSORT statement and its impact on quality of reporting of trials
por: Ranganathan, Priya
Publicado: (2019)

Visualization of Traditional Chinese Medicine Formulas: Development and Usability Study
por: Wu, Zhiyue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ahajog4tnkc458ivkp49j21je0